Ownership history in Ghost Tree Capital, LLC Β· 17 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in TG THERAPEUTICS INC (TGTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Ghost Tree Capital, LLC outperformed the S&P 500 by +58.2% annually on this TGTX position. Timing score: 67% (10/15 decisions correct). Average cost basis: $15.82. Maximum drawdown during holding period: β83.9%.
π₯ Exceptional β beat the S&P 500 by 58.2% per year on this position.
15 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
10 of 15 add/trim decisions correct
Best entry: $8.36 (2023 Q3) Β· Worst: $52.02 (2020 Q4)
πͺ Held through 2 major drawdowns (>20%).
8 adds Β· 9 trims. Bought during 4 of 7 down-price quarters. π Predominantly trimming β distribution phase.
π Ghost Tree Capital, LLC has been actively increasing its TGTX allocation β a bullish signal from insiders.
Currently 2.19% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size